Back to Results
First PageMeta Content
Health / Clinical research / Health in Canada / Health Products and Food Branch / Drug Identification Number / Therapeutic Products Directorate / Natural Health Products Directorate / Good manufacturing practice / Food and Drug Administration / Health Canada / Pharmaceutical sciences / Pharmacology


Record of Decisions[removed] : Consumer Health Products Canada (CHP Canada)
Add to Reading List

Document Date: 2013-06-24 11:49:29


Open Document

File Size: 39,21 KB

Share Result on Facebook

City

Ottawa / Toronto / /

Company

GlaxoSmithKline Consumer Healthcare Inc. / Marketed Pharmaceuticals / Johnson & Johnson Inc. / Procter & Gamble Inc. / Consumer Health Products Canada / Services Inc. / Schering-Plough Canada Inc. / Pfizer / Directorate Working Group / Pfizer Canada Inc. / McCarthy / /

Country

Canada / The Netherlands / /

Event

FDA Phase / Person Communication and Meetings / /

Facility

Ivey Centre / Main Stats Building / University of Western Ontario / Finance Building / /

IndustryTerm

manufacturing changes / pharmaceutical industry / risk management / non-prescription drug products / social media / health products / natural health products / sunscreen applications / therapeutic products / pharmaceutical programs / /

MedicalCondition

Viral Diseases / Infection / /

Organization

Policy / Planning and International Affairs Directorate / Bureau of Pharmaceutical Sciences / Public Health Agency of Canada / Acetaminophen and CHP Canada’s Acetaminophen Task Force / Biologics and Genetic Therapies Directorate / Health Products Directorate / Bureau of Gastroenterology / Information Management Services Directorate / Ivey Centre for Health Innovation and Leadership / University of Western Ontario / Health Products and Food Branch / Liaison Unit / office of Consumer and Public Involvement / office of Business Transformation / Therapeutic Products Directorate / OTC Committee / Director General’s Office / Bureau of Policy / Science and International Programs / Red Tape Reduction Commission / Medical Devices Bureau / Bureau of Metabolism / Oncology and Reproductive Sciences / /

Person

Todd Breedon / Supriya Sharma / Andrew M. Adams / Mandy Collier / Hieu D. Vu / Regrets Supriya Sharma / Barbara J. Sabourin / Nashwa Irfan / Priorities Kim Dayman-Rutkus / Initiatives Lisa Lange / Robert White / Ratna Bose / Barbara Rotter / Nicki Smith / Katie Greenwood / Osama A. Wahid / Andy Hua / Kristin Willemsen / Jennifer Denommé / Julie Woo / Sonia Roussel / Lisa Lange / Jacques Bouchard / David Skinner / Paul Litowitz / Christine Leroux / Hieu Vu / Genevieve Moore / Virginie Mongeon / Isabel Renart-McGowan / Tessa Hogerwaard / Carol Newell / /

Position

Executive Director / President / Policy Analyst / Consultant / Director General / Senior Executive Director / Acting Director / Director / Manager / NDED / BGIVD / Co-Chair / Manager / Nonprescription Drug Evaluation Division / Forward Planning / Director / Policy and Strategic Planning Division / Director / Policy and Strategic Planning Division / /

Product

Acetaminophen / New Drug / /

PublishedMedium

The Compliance Verification Review / /

Region

Western Ontario / /

SocialTag